Not Yet RecruitingNCT07639099
Official study titleImpact of Intranasal Esketamine-dexmedetomidine Combination on Postpartum Depression in Parturients With Prenatal Depressive Symptoms: a Randomized, Double-blind, and Placebo-controlled Trial
This study isn't recruiting yet.
In BeijingDepressionMedication studyAges 18+
- Countries
- China
- Sponsor
- Peking University First Hospital
Not Yet RecruitingNCT07499583
Official study titlePsilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
This study isn't recruiting yet.
In IndianapolisDepression, AddictionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Indiana University
Not Yet RecruitingNCT06101914
Official study titleEvaluating the Occurrence of Engagement Patterns and Participation Trends Among Patients in Treatment Resistant Depression
This study isn't recruiting yet.
In San FranciscoDepressionObservational studyAges 18+
- Countries
- United States
- Sponsor
- Power Life Sciences Inc.
Enrolling By InvitationNCT06044324
What is this study about?This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
This study is by invitation only.
In HangzhouDepressionDevice studyAges 18–45
- Countries
- China
- Sponsor
- First Affiliated Hospital of Zhejiang University
RecruitingACTRN12611000541909
Official study titleThe utility of combining cognitive processing therapy and behavioural activation for individuals with comorbid posttraumatic stress disorder and major depressive disorders: Is there added benefit to combining treatments?
Location not clearly listedDepression, PTSDInterventional studyAges 16+
- Countries
- Sponsor
- Samantha Angelakis
Not Yet RecruitingACTRN12625000329460
Official study titleA Randomised, Controlled Trial to Investigate the Effect of a six-week Intensified Pharmacological Treatment for Major Depressive Disorder, compared to Treatment as Usual in Participants Who Had a First-time Treatment Failure on Their First-line Treatment for -Major Depressive Disorder Cohort.
This study isn't recruiting yet.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Northern Adelaide Local Health Network
RecruitingNCT07196501
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
Multiple locations, including OceansideDepressionMedication studyAges 18+
- Countries
- United States, Australia, Canada, + 8 others
- Sponsor
- Neurocrine Biosciences (Biotech company)